BioIgnite

Name: BioIgnite
SKU: 14253
Availability: InStock

$399.00

Description

BioIgnite

BioIgnite is a metabolic/thermogenic supplement from BioLongevity Labs. It is marketed for fat oxidation, energy production, focus, and metabolic activation. According to product information, each capsule contains:

L-Theanine — 150 mg
Caffeine — 50 mg
Amlexanox — 50 mg (prescription anti-inflammatory drug)
Albuterol — 3 mg (prescription beta-2 adrenergic agonist, used medically for asthma)

Note: The inclusion of Albuterol and Amlexanox (pharmaceutical compounds) makes this product distinct from typical dietary supplements. These are prescription medications in most countries and are not standard supplement ingredients.

Intended Effects (Claimed)

The formula aims to enhance thermogenesis, fat burning, glucose disposal, insulin sensitivity, and mitochondrial energy production while providing focus without a heavy crash.

Safety Profile

Known Components:

Caffeine + L-Theanine: Common and generally well-tolerated at these doses. The combination is known for providing smooth focus and energy with reduced jitteriness. Side effects may include mild anxiety, insomnia, or increased heart rate, especially in caffeine-sensitive individuals.
Amlexanox (50 mg): Used medically for mouth ulcers. It inhibits certain inflammatory pathways (IKK-ε/TBK1). Limited data on long-term oral use for metabolic purposes. Potential side effects include gastrointestinal discomfort, nausea, or allergic reactions.
Albuterol (3 mg oral): A potent bronchodilator. Oral use can cause significant cardiovascular stimulation (increased heart rate, palpitations, tremors, blood pressure changes), anxiety, headaches, and muscle cramps. At 3 mg, this is a pharmacologically active dose. Misuse or overuse of beta-2 agonists carries risks of cardiac arrhythmias, hypokalemia (low potassium), and tolerance development.

Potential Risks and Concerns

Cardiovascular Strain: The combination of caffeine + albuterol may amplify heart rate and blood pressure increases, posing risks for individuals with hypertension, heart conditions, or arrhythmias.
Drug-Like Effects: Because it contains prescription pharmaceuticals, BioIgnite may produce stronger stimulant and metabolic effects than typical supplements, along with corresponding risks.
Unknown Long-Term Safety: There are limited clinical studies on this specific combination for metabolic/fat-loss use. The long-term impact of daily albuterol and amlexanox at these doses is not well-established for healthy individuals.
Interactions: High risk when combined with other stimulants, beta-blockers, MAOIs, or medications affecting heart rate/blood pressure.
Regulatory Concerns: Products containing undeclared or unapproved prescription ingredients in supplements may raise compliance issues in various jurisdictions.

Contraindications

Cardiovascular disease, high blood pressure, arrhythmias
Anxiety disorders or thyroid issues
Pregnancy or breastfeeding
Anyone taking prescription medications (especially for asthma, heart conditions, or mental health)

Important Note: This is a neutral, educational overview based on available product information and known pharmacology of its ingredients. BioIgnite is not a typical dietary supplement due to the presence of pharmaceutical compounds. Significant safety uncertainties exist regarding long-term use. This information is not medical advice and does not encourage use. Consult a qualified healthcare professional before considering this or any similar product, especially if you have pre-existing conditions or take medications. Always verify product legality and quality in your region.

Delivery Details

2-3 days from the time of purchase to all locations

Order now and enjoy great discounts! We deliver top-quality peptide products straight to you. Fast, reliable, and discreet service. Delivery hours: 10 AM–8 PM daily. Don’t miss out

Research

L-Theanine activates AMPK and upregulates UCP1 and PRDM16, promoting browning of white adipose tissue and increasing adaptive thermogenesis in obese mice [1][2]. Caffeine increases 24-hour energy expenditure by ~100 kcal when consumed in multiple doses (~600 mg total) [10][11], mediated by enhanced lipolysis and BAT activation [12]. Albuterol (salbutamol) directly stimulates β₂ receptors in human brown fat, acutely raising resting metabolic rate and lipid utilization [6][7]. In rats, the combination of albuterol with caffeine produced significantly greater lean mass gain and fat loss compared to either agent alone [6].

Glucose Disposal & Insulin Sensitivity

L-Theanine supplementation improved glucose tolerance and insulin sensitivity in diet-induced obese mice, lowering plasma triglycerides and cholesterol [2][3]. Amlexanox increased insulin sensitivity in obese mice [4] and improved HbA1c in a subset of type 2 diabetic patients, particularly those with inflammatory adipose signatures [5]. Albuterol enhances glucose uptake in skeletal muscle and BAT during β₂ activation, supporting systemic glucose clearance [6][7].

Anti-inflammatory Metabolic Support

Amlexanox inhibits obesity-induced IKK-ε/TBK1 signaling, a pathway that normally suppresses energy expenditure and promotes adipose inflammation [4]. By blocking this brake, amlexanox restores catecholamine responsiveness in adipocytes, increases FGF21 secretion, and improves fatty liver disease [5]. L-Theanine also exerts antioxidant and anti-inflammatory actions in liver and fat tissue, supporting better insulin receptor signaling [3].

Mitochondrial & Energy Metabolism

Caffeine preserves mitochondrial function by upregulating biogenesis pathways via AMPK and catecholamine signaling [10][12]. L-Theanine enhances oxidative metabolism through AMPK–α-ketoglutarate coupling [1]. Albuterol increases mitochondrial uncoupling in BAT and enhances fat oxidation in skeletal muscle [6][7]. Together, these effects foster efficient fuel utilization and higher metabolic rate.

References

Front Endocrinol. 2024 – L-Theanine activates AMPK, drives adipose browning via PRDM16 demethylation. https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2024.1458848/pdf
Peng et al. Diabetes. 2021 – L-Theanine increases adaptive thermogenesis & improves insulin sensitivity in obese mice. https://pubmed.ncbi.nlm.nih.gov/33863801/
Front Nutr. 2022 – L-Theanine intake linked with reduced diabetes risk and improved glucose handling. https://www.frontiersin.org/journals/nutrition/articles/10.3389/fnut.2022.853846/full
Reilly et al. Nat Med. 2013 – Amlexanox inhibits IKK-ε/TBK1, reverses obesity-induced inflammation, increases energy expenditure. https://pubmed.ncbi.nlm.nih.gov/23396211/
Oral et al. Cell Metab. 2017 – Amlexanox improves HbA1c and fatty liver in inflammatory type 2 diabetes subset. https://www.lsi.umich.edu/news/2017-07/repurposed-asthma-drug-shows-blood-sugar-improvement-among-some-diabetics
Schreiber et al. Obesity. 2015 – Albuterol + caffeine combo increases lean mass, reduces fat mass in rats. https://pmc.ncbi.nlm.nih.gov/articles/PMC4551658/
Straat et al. Cell Rep Med. 2023 – Salbutamol activates human brown adipose tissue and increases whole-body energy expenditure. https://www.researchgate.net/publication/368698239_Stimulation_of_the_beta-2-adrenergic_receptor_with_salbutamol_activates_human_brown_adipose_tissue
PubMed 33863801 – AMPK activation required for L-Theanine-induced WAT browning. https://pubmed.ncbi.nlm.nih.gov/33863801/
LSI Michigan 2017 – Repurposed asthma drug (amlexanox) improves blood sugar and fatty liver in humans. https://www.lsi.umich.edu/news/2017-07/repurposed-asthma-drug-shows-blood-sugar-improvement-among-some-diabetics
Front Physiol. 2021 – Caffeine increases energy expenditure and fat oxidation in humans. https://pmc.ncbi.nlm.nih.gov/articles/PMC7889509/
Astrup et al. 1990 – Caffeine raises 24h energy expenditure in humans. https://pmc.ncbi.nlm.nih.gov/articles/PMC7889509/
Murphy et al. 2017 – Caffeine antagonism of adenosine receptors activates orexin neurons, driving BAT thermogenesis. https://pmc.ncbi.nlm.nih.gov/articles/PMC7889509/

Note: BioIgnite is supplied strictly for investigational research use only. It is not approved or intended for diagnostic or therapeutic applications in humans or animals.

COAs